NYSE:HYH

Halyard Health (HYH) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$56.93
$57.91
50-Day Range
N/A
52-Week Range
$38.22
$61.52
Volume
886,271 shs
Average Volume
438,537 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
HYH stock logo

About Halyard Health Stock (NYSE:HYH)

Avanos Medical, Inc. operates as a medical technology company. It focuses on delivering clinically medical device solutions to improve patients' quality of life. The firm's portfolio of product offerings focuses on respiratory and digestive health, along with surgical and interventional pain management to improve patient outcomes and reduce the cost of care. Its brands include ON-Q, Coolife, Microcuff, MIC-Key, Quilbloc and Home pump. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.

HYH Stock News Headlines

HALYARD PRINCIPALS LLC's Net Worth
Health Care
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.
Avanos Medical Inc (AVNS)
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.
Halyard Health Announces New Drainage System, Stock Down
See More Headlines
Receive HYH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Halyard Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/01/2017
Today
4/26/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical Appliances & Supplies
Sub-Industry
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Joseph F. Woody
    Chief Executive Officer & Executive Director
  • Michael C. Greiner
    Chief Financial Officer & Senior Vice President
  • Lee Burnes
    Senior VP-Global Research & Development
  • Michelle Scharfenberg
    Senior VP, Chief Ethics & Compliance Officer
  • Rhonda D. Gibby
    Chief Human Resources Officer & Senior VP

HYH Stock Analysis - Frequently Asked Questions

How were Halyard Health's earnings last quarter?

Halyard Health, Inc. (NYSE:HYH) released its quarterly earnings results on Wednesday, November, 1st. The medical instruments supplier reported $0.60 EPS for the quarter, beating analysts' consensus estimates of $0.47 by $0.13. The medical instruments supplier had revenue of $401.40 million for the quarter, compared to analysts' expectations of $394.54 million. The firm's revenue for the quarter was up 1.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.48 earnings per share.

What other stocks do shareholders of Halyard Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Halyard Health investors own include Kimberly-Clark (KMB), Allergan (AGN), Cisco Systems (CSCO), General Electric (GE), Kinder Morgan (KMI), Gilead Sciences (GILD), Intel (INTC), Ionis Pharmaceuticals (IONS) and Johnson & Johnson (JNJ).

This page (NYSE:HYH) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners